Having these genetic tests available has also facilitated the confirmation of INAD diagnosis with the identification of pathogenic variants in the PLA2G6 gene, even avoiding invasive biopsies [2],[10],[15],[20],[21]. This evidence concerns the gene PLA2G6 and neurodegeneration with brain iron accumulation 2A.